Inhalerx Ltd (IRX) — Strategic Asset Allocation Index
Inhalerx Ltd (IRX) has a Strategic Asset Allocation Index of 0.0% as of December 2022. Strategic assets (PP&E of AU$0.00 plus long-term investments of AU$-) total AU$0.00, measured against net assets of AU$1.93 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Inhalerx Ltd (IRX) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Inhalerx Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Inhalerx Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2022. As of December 2022, the index stands at 0.0%, representing strategic assets of AU$0.00 against net assets of AU$1.93 Million AUD. See IRX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Inhalerx Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Inhalerx Ltd from 2016 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see IRX company net worth.
| Year | SAAI | Strategic Assets (AUD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | AU$0.00 | AU$0.00 | AU$- | AU$1.90 Million | ▼ -0.4 pp |
| 2021 | 0.4% | AU$9.71K | AU$9.71K | AU$- | AU$2.68 Million | ▲ +0.4 pp |
| 2019 | 0.0% | AU$0.00 | AU$0.00 | AU$- | AU$340.08K | ▼ -3.6 pp |
| 2018 | 3.6% | AU$96.11K | AU$96.11K | AU$- | AU$2.68 Million | ▲ +2.4 pp |
| 2017 | 1.2% | AU$54.43K | AU$54.43K | AU$- | AU$4.51 Million | ▲ +0.8 pp |
| 2016 | 0.4% | AU$27.00K | AU$27.00K | AU$- | AU$7.33 Million | — |